Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets.
Recursion Pharma is a Salt Lake City-based drug discovery company founded in 2013 based on technology developed at the University of Utah. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions.
-
Industry
-
Milestones
- Lux investment: 2016
-
Founders
- Chris Gibson, PhD
- Blake Borgeson, PhD
- Dean Li, PhD
LUX Partners
-
Latest Tweets
- Co-Founder & CEO @RecursionChris will discuss "digital biology: the future of #DrugDiscovery today" with our Scient… https://t.co/bCBdzSpb3s
- President & COO @TinaMarrLarson will present "Demystifying #ArtificialIntelligence in #Biopharma" tomorrow for… https://t.co/cEkOat9veU
- We're honored to make @Forbes #AI 50 list as one of America’s most promising #ArtificialIntelligence companies. Rea… https://t.co/k7NUFIZeeG
